Nutrition 21 (NXXI) soared 22% Tuesday after the company said a study showed its Selenomax product stopped progression of the HIV virus.The Purchase, N.Y., company said the benefits were reported in a five-year, double-blind, placebo-controlled study conducted by researchers at the University of Miami and published in the Jan. 22 issue of the American Medical Association's Archives of Internal Medicine.
Nutrition 21 Soars
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.